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New Evidence for ITN
Effectiveness
There is robust evidence of the efficacy
of insecticide-treated mosquito nets (ITNs)
in reducing malaria parasite prevalence,
incidence, and all-cause child mortality
from carefully conducted trials in sub-
Saharan Africa across a range of trans-
mission settings [1]. Trials have shown
ITNs to both significantly reduce Plasmo-
dium falciparum prevalence among children
under 5 years old by 13% and post-
neonatal (1–59 months) all-cause mortality
by 18% in areas of stable malaria
transmission in Africa [1,2]. However,
there have been limited data on the
effectiveness of ITNs under routine pro-
gram conditions at preventing malaria
morbidity and child mortality, especially
at the national level. This has of course
raised serious concerns abou how likely
the efficacy of ITNs from trials is translat-
ing into real-world effectiveness on the
ground. There are certainly examples
where a proven effective intervention
achieved disappointing results when pro-
grams ran into constraints with deploy-
ment at wide-scale implementation [3,4].
Stephen Lim and colleagues, in an
article published in this week’s PLoS
Medicine, should be commended for their
rigorous and systematic analysis of nation-
al cross-sectional survey datasets in sub-
Saharan Africa assessing the association of
ITNs on reducing P. falciparum prevalence
in children under 5 and all-cause post-
neonatal mortality, while controlling for
contextual and potential confounding
factors [5]. The results show ITN house-
hold possession to be associated with a
20% significant reduction in P. falciparum
prevalence (from seven surveys in seven
countries) and a 23% significant reduction
in all-cause child mortality (from 29
surveys in 22 countries). Importantly, these
results were consistent across a range of
malaria transmission settings and across
countries with disparate levels of ITN
household coverage. They are also consis-
tent with data from smaller-scale studies
that have shown ITNs to be associated
with significant reductions in malaria
under program conditions [6–10].
The ITN represents a brilliant inter-
vention—it provides individual protection
to the person sleeping under it from
infected mosquitoes; the insecticide kills
mosquitoes that seek a blood meal thereby
reducing the overall propensity for trans-
mission in the community [11,12]; and if
the person under the net is already
infected with the malaria parasite, the
ITN prevents them from infecting mos-
quitoes and leading to more transmission.
The ITN is tailored to the biology of the
African malaria-carrying Anopheles mosqui-
toes that prefer to bite humans, bite late at
night when people are sleeping (hopefully
under an ITN), and rest on vertical
surfaces (such as the walls of the ITN)
while they digest their blood meal. Na-
tional ITN mass distribution campaigns
have achieved remarkably high household
coverage, even among the most poor and
rural areas [13–15]. Despite unsubstanti-
ated anecdotes of misuse and non-use
[16], given sufficient access to ITNs people
use them for protection against malaria
[17].
Still, ITNs are not the sole answer to
malaria control, and they cost money and
need to be continually replaced when they
wear out.
Relevance to Malaria Control
Funding for malaria control has in-
creased dramatically from ,US$100
million available in 2003 to ,U$1.5
billion available in 2010, with over three-
quarters going to sub-Saharan Africa [18].
Largely based on the results of the ITN
trials, there has been a considerable ’’leap
of faith’’ by international donors and
ministries of health across Africa in relying
on ITNs as a cornerstone malaria preven-
tion tool that will translate into real gains
on the ground in reducing the malaria
burden. To this end between 2004 and
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Lim SS, Fullman N, Stokes A, Ravishan-
k a rN ,M a s i y eF ,e ta l .( 2 0 1 1 )N e t
Benefits: A Multi-Country Analysis of
Observational Data Examining Asso-
ciations between Insecticide-Treated
Mosquito Nets and Health Outcomes.
PLoS Med 8(9): e1001091. doi:10.
1371/journal.pmed.1001091
Stephen Lim and colleagues report
findings from a multi-country anal-
ysis of household survey data on
the association between possession
of insecticide-treated mosquito nets
and child mortality and parasitemia.
Scale-up of net coverage was asso-
ciated with a substantial reduction
in childhood mortality and in para-
sitemia prevalence.
PLoS Medicine | www.plosmedicine.org 1 September 2011 | Volume 8 | Issue 9 | e10010882010, manufacturers delivered more than
400 million nets, with 290 million deliv-
ered since 2008, which is sufficient to
cover nearly 80% of populations at risk of
malaria in Africa [18].
After nearly a decade of investment in
malaria control across Africa, there has been
a critical need to evaluate the impact this
effort has had on reducing the malaria
burden, especially for child mortality. How-
ever, because nearly all national programs
are scaling-up to achieve fullcoverage of
populations at risk of malaria, evaluators
must rely on an ecological, or plausibility,
study design whe attempting to assess the
impact of malaria control investments [19–
21], whereby changes in intervention cov-
erage are measured against simultaneous
changes in malaria morbidity and mortality.
If the malaria burden is observed to decrease
concurrently with intervention coverage in
the population, then one deems it plausible
tha the program contributed to the im-
proved outcomes observed. Thisis especially
true for ITNs where there are robust
empirical data from trials on their efficacy.
However, the study design is strengthened
immenselywhenthere isadditional evidence
that the effect seen in trial translates to
effectiveness on the ground.
Lim and colleagues have provided
timely and vital validating evidence that
national programs can decrease malaria
morbidity and child mortality through
program investments in ITNs. In a world
of shrinking resources for global health
programs, such evidence is critically im-
portant. To emphasize this point, consider
what it would have meant if the analysis by
Lim and colleagues had shown that
despite the evidence from trials, ITNs
have no demonstrable association with
reducing malaria morbidity and child
mortality under program conditions in
Africa; this would have been devastating to
the integrity of past and future investments
in ITNs as a primary tool in the fight
against malaria. In fact, they found the
opposite and confidence, renewed atten-
tion, and investment should follow.
Next Steps
The next 5 to 10 years will be critical in
the fight against malaria, especially if
elimination in areas of Africa is to be
achieved. As Lim and colleagues suggest,
continued scale-up of long-lasting ITNs
(LLINs) must be a cornerstone of this
effort and there are still lives to be saved
with this intervention. LLINs typically
wear out after 2–3 years and thus the
malaria control community must attend to
finding the most efficient means of replac-
ing worn out nets once high coverage has
been achieved [22]. And, ITNs alone are
insufficient to completely eliminate malar-
ia transmission in areas of Africa suitable
to perennial transmission [23]. It is
therefore imperative for the malaria com-
munity to apply its program experience
and success with ITNs towards a focus on
testing new tools and delivery approaches
to achieve the next level of malaria
transmission reduction beyond what is
achievable by high ITN coverage alone
[24–26].
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